Department of Molecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Am J Surg Pathol. 2012 Apr;36(4):589-600. doi: 10.1097/PAS.0b013e3182475240.
Birt-Hogg-Dubé (BHD) syndrome is an autosomal dominant disorder characterized by fibrofolliculomas, renal tumors, and pulmonary cysts with recurrent pneumothorax. Multiple pulmonary cysts and pneumothorax are the key signs for diagnosing BHD syndrome. The pathologic features of BHD pulmonary cysts, however, are poorly understood. This disorder is caused by mutations in the gene that encodes folliculin (FLCN). FLCN is regarded as a tumor suppressor; it mediates cellular activities by interacting with the mammalian target of rapamycin (mTOR). In this study, we investigated the lungs of 11 patients from 9 BHD families. The majority of patients consulting doctors were women between 30 and 60 years of age who had pulmonary cysts and repeated pneumothoraces. Genomic DNA testing revealed 5 different mutation patterns. Histopathologic examination found that the inner surface of cysts was lined by epithelial cells, sometimes with a predominance of type II pneumocyte-like cuboidal cells. The cysts occasionally contained internal septa consisting of alveolar walls or showed an "alveoli within an alveolus" pattern. The cells constituting the cysts stained positive for phospho-S6 ribosomal protein expression, suggesting activation of the mTOR pathway. Although BHD pulmonary cysts are frequently misdiagnosed as nonspecific cystic diseases, they are distinctly different in histopathology from other bullous changes. Mechanical stress such as rupture and postrupture remodeling allows mesothelial invagination and fibrosis. Such modified BHD pulmonary cysts are virtually indistinguishable from nonspecific blebs and bullae. We propose a new insight, namely, that the BHD syndrome-associated pulmonary cyst may be considered a hamartoma-like cystic alveolar formation associated with deranged mTOR signaling.
Birt-Hogg-Dubé (BHD) 综合征是一种常染色体显性遗传病,其特征为多发性毛发纤维瘤、肾肿瘤和反复发生气胸的肺囊肿。多发性肺囊肿和气胸是诊断 BHD 综合征的关键征象。然而,BHD 肺囊肿的病理特征尚未完全了解。该疾病是由编码成纤维细胞瘤抑制因子 (FLCN) 的基因突变引起的。FLCN 被认为是一种肿瘤抑制因子;它通过与哺乳动物雷帕霉素靶蛋白 (mTOR) 相互作用来调节细胞活动。在这项研究中,我们研究了来自 9 个 BHD 家族的 11 名患者的肺部。前来就诊的大多数患者是年龄在 30 岁至 60 岁之间的女性,她们患有肺囊肿和反复气胸。基因组 DNA 测试显示了 5 种不同的突变模式。组织病理学检查发现,囊肿的内表面由上皮细胞衬里,有时以 II 型肺泡细胞样立方细胞为主。囊肿偶尔包含由肺泡壁组成的内部隔膜,或表现出“肺泡内的肺泡”模式。构成囊肿的细胞对磷酸化 S6 核糖体蛋白表达呈阳性染色,表明 mTOR 通路的激活。尽管 BHD 肺囊肿常被误诊为非特异性囊性疾病,但它们在组织病理学上与其他大疱性改变明显不同。机械应力如破裂和破裂后重塑允许间皮内陷和纤维化。这种改良的 BHD 肺囊肿几乎与非特异性疱和大疱无法区分。我们提出了一个新的观点,即 BHD 综合征相关的肺囊肿可能被认为是一种与 mTOR 信号异常相关的类瘤样囊性肺泡形成。